Top Wall Street Forecasters Revamp AngioDynamics Expectations Ahead Of Q1 Earnings

Benzinga

Oct 01

AngioDynamics, Inc. (NASDAQ:ANGO) will release earnings results for the first quarter, before the opening bell on Thursday, Oct. 2.

Analysts expect the Latham, New York-based company to report a quarterly loss at 12 cents per share, versus a year-ago loss of 11 cents per share in the year-ago period. AngioDynamics projects to report quarterly revenue at $72.69 million, compared to $67.49 million a year earlier, according to data from Benzinga Pro.

On July 15, AngioDynamics reported better-than-expected fourth-quarter financial results and issued FY26 revenue guidance above estimates.

Shares of AngioDynamics rose 4% to close at $11.17 on Tuesday.

Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.

Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.

HC Wainwright & Co. analyst Yi Chen reiterated a Buy rating with a price target of $16 on July 16, 2025. This analyst has an accuracy rate of 64%.
Canaccord Genuity analyst William Plovanic maintained a Buy rating and boosted the price target from $15 to $17 on July 16, 2025. This analyst has an accuracy rate of 57%.

Considering buying ANGO stock? Here’s what analysts think:

Read This Next:

Top 2 Energy Stocks You May Want To Dump This Month

Photo via Shutterstock

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2572553245"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2572553245\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2572553245?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-01 21:57","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2572553245","market":"hk","top_or_hot":-1,"title":"Top Wall Street Forecasters Revamp AngioDynamics Expectations Ahead Of Q1 Earnings","media":"Benzinga","content":"<html><body><p><strong>AngioDynamics, Inc.</strong> (NASDAQ:ANGO) will release earnings results for the first quarter, before the opening bell on Thursday, Oct. 2.</p>\n<p>Analysts expect the Latham, New York-based company to report a quarterly loss at 12 cents per share, versus a year-ago loss of 11 cents per share in the year-ago period. AngioDynamics projects to report quarterly revenue at $72.69 million, compared to $67.49 million a year earlier, according to data from Benzinga Pro.</p>\n<p>On July 15, AngioDynamics reported better-than-expected fourth-quarter financial results and issued FY26 revenue guidance above estimates.</p>\n<p>Shares of AngioDynamics rose 4% to close at $11.17 on Tuesday.</p>\n<p>Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.</p>\n<p>Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.</p>\n<ul>\n<li>HC Wainwright &amp; Co. analyst Yi Chen reiterated a Buy rating with a price target of $16 on July 16, 2025. This analyst has an accuracy rate of 64%.</li>\n<li><a href=\"https://laohu8.com/S/CCORF\">Canaccord Genuity</a> analyst William Plovanic maintained a Buy rating and boosted the price target from $15 to $17 on July 16, 2025. This analyst has an accuracy rate of 57%.</li>\n</ul>\n<p>Considering buying ANGO stock? Here’s what analysts think:</p>\n<p><strong>Read This Next:</strong></p>\n<ul>\n<li><strong> Top 2 Energy Stocks You May Want To Dump This Month</strong></li>\n</ul>\n<p>Photo via Shutterstock</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Top Wall Street Forecasters Revamp AngioDynamics Expectations Ahead Of Q1 Earnings</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTop Wall Street Forecasters Revamp AngioDynamics Expectations Ahead Of Q1 Earnings\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2025-10-01 21:57</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p><strong>AngioDynamics, Inc.</strong> (NASDAQ:ANGO) will release earnings results for the first quarter, before the opening bell on Thursday, Oct. 2.</p>\n<p>Analysts expect the Latham, New York-based company to report a quarterly loss at 12 cents per share, versus a year-ago loss of 11 cents per share in the year-ago period. AngioDynamics projects to report quarterly revenue at $72.69 million, compared to $67.49 million a year earlier, according to data from Benzinga Pro.</p>\n<p>On July 15, AngioDynamics reported better-than-expected fourth-quarter financial results and issued FY26 revenue guidance above estimates.</p>\n<p>Shares of AngioDynamics rose 4% to close at $11.17 on Tuesday.</p>\n<p>Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.</p>\n<p>Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.</p>\n<ul>\n<li>HC Wainwright &amp; Co. analyst Yi Chen reiterated a Buy rating with a price target of $16 on July 16, 2025. This analyst has an accuracy rate of 64%.</li>\n<li><a href=\"https://laohu8.com/S/CCORF\">Canaccord Genuity</a> analyst William Plovanic maintained a Buy rating and boosted the price target from $15 to $17 on July 16, 2025. This analyst has an accuracy rate of 57%.</li>\n</ul>\n<p>Considering buying ANGO stock? Here’s what analysts think:</p>\n<p><strong>Read This Next:</strong></p>\n<ul>\n<li><strong> Top 2 Energy Stocks You May Want To Dump This Month</strong></li>\n</ul>\n<p>Photo via Shutterstock</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ANGO","symbol_name":"Angiodynamics","start_time":0,"source_url":"https://www.benzinga.com/analyst-stock-ratings/price-target/25/10/47968672/top-wall-street-forecasters-revamp-angiodynamics-expectations-ahead-of-q1-earnings","article_id":"2572553245","we_media_id":"1052270027","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2572553245","pubTimestamp":1759327077,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Benzinga","introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"summary":" ","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"ANGO":"Angiodynamics"},"translate_title":"华尔街顶级预测者在第一季度盈利前修改了血管动力学预期","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ANGO":1.5},"content_text":"AngioDynamics, Inc. (NASDAQ:ANGO) will release earnings results for the first quarter, before the opening bell on Thursday, Oct. 2.\nAnalysts expect the Latham, New York-based company to report a quarterly loss at 12 cents per share, versus a year-ago loss of 11 cents per share in the year-ago period. AngioDynamics projects to report quarterly revenue at $72.69 million, compared to $67.49 million a year earlier, according to data from Benzinga Pro.\nOn July 15, AngioDynamics reported better-than-expected fourth-quarter financial results and issued FY26 revenue guidance above estimates.\nShares of AngioDynamics rose 4% to close at $11.17 on Tuesday.\nBenzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.\nLet's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.\n\nHC Wainwright & Co. analyst Yi Chen reiterated a Buy rating with a price target of $16 on July 16, 2025. This analyst has an accuracy rate of 64%.\nCanaccord Genuity analyst William Plovanic maintained a Buy rating and boosted the price target from $15 to $17 on July 16, 2025. This analyst has an accuracy rate of 57%.\n\nConsidering buying ANGO stock? Here’s what analysts think:\nRead This Next:\n\n Top 2 Energy Stocks You May Want To Dump This Month\n\nPhoto via Shutterstock","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport,express","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}